In addition to positive cardiovascular effects, systemic Ang-(1-7) infusion improves metabolic outcomes in animal models of hypertension, obesity, diabetes, cardiometabolic syndrome, and aging. The gene discussed is ANG; the disease is obesity due to melanocortin 4 receptor deficiency.